Manufacturing of clinical supplies up to commercial quantities of APIs, formulations, and complete products for inhalation and nasal dosage forms, including metered dose inhalers (MDIs), dry powder inhalers (DPIs), inhalation solutions, and nasal sprays
Lonza provides integrated DPI (dry powder inhaler) services to advance molecules, drawing on 25 years of experience in particle engineering, formulation design, and encapsulation techniques. Our premier particle engineering services, utilizing both micronization and spray drying techniques, are tailored to your molecule, target product profile and delivery device. Dedicated DPI formulation and manufacturing teams ensure that development timelines are met while minimizing program risk and complexity.
Unlock sustainable pulmonary & nasal drug delivery with Kindeva. We are the first CDMO to offer green propellant capabilities for HFA-152a and HFO-1234ze, with clinical supply already available and commercial scale in 2024. Backed by over half a century of experience, industry-leading capacity, and unmatched capabilities, we help streamline your first-in-human timeline, minimize risk, and maximize success. Combine forces with us to discover proactive, informed solutions and a collaborative approach to your product’s development and manufacturing needs.
Bespak offers integrated services to support inhalation and nasal drug delivery; from initial combination device design, to formulation development, through to manufacturing. Our solutions span across the full product lifecycle, to help provide drug delivery devices to patients globally. These include pressurised metered dose inhalers (pMDIs), soft mist inhalers (SMIs) and multi dose and single dose nasal spray devices. Our experts have extensive knowledge throughout the entire lifecycle of drug product development to market, as well as accelerating routes to market. Bespak is your true expert CDMO partner for integrated inhalation and nasal platform offerings.
Expertise and proven success in pulmonary & nasal delivery: Catalent is your preferred CDMO for pulmonary and nasal delivery, with clinical to commercial-scale development and manufacturing capabilities for dry powder inhalers, as well as liquid and powder unit-dose, bi-dose and multi-dose nasal sprays. With over 30 years of inhalation product experience and state-of-the-art facilities in Boston, MA and Morrisville, NC Catalent can handle the most complex projects and help bring your inhaled therapy to market, faster.
Would you like to list your company in this section or upgrade your existing listing? For information about supplier listing options, click here.